78 results about "CPR - Cardiopulmonary resuscitation" patented technology

The invention provides a compound of the formula (I) for use in the prophylaxis or treatment of a disease state or condition mediated by a cyclin dependent kinase: wherein A is a group R2 or CH2—R2 where R2 is a carbocyclic or heterocyclic group having from 3 to 12 ring members; B is a bond or an acyclic linker group having a linking chain length of up to 3 atoms selected from C, N, S and O; R1 is hydrogen or a group selected from SO2Rb, SO2NR7R8, CONR7R8, NR7R9 and carbocyclic and heterocyclic groups having from 3 to 7 ring members; R3, R4, R5 and R6 are the same or different and are each selected from hydrogen, halogen, hydroxy, trifluoromethyl, cyano, nitro, carboxy, amino, carbocyclic and heterocyclic groups having from 3 to 12 ring members; a group Ra—Rb wherein Ra is a bond, O, CO, X1C(X2), C(X2)X1, X1C(X2)X1, S, SO, SO2, NRc, SO2NRc or NRcSO2; and Rb is selected from hydrogen, carbocyclic and heterocyclic groups having from 3 to 12 ring members, and a C1-8 hydrocarbyl group optionally substituted by one or more substituents selected from hydroxy, oxo, halogen, cyano, nitro, amino, mono- or di-C1-4 hydrocarbylamino, carbocyclic and heterocyclic groups having from 3 to 12 ring members and wherein one or more carbon atoms of the C1-8 hydrocarbyl group may optionally be replaced by O, S, SO, SO2, NRc, X1C(X2), C(X2)X1 or X1C(X2)X1; Rc is hydrogen or C1-4 hydrocarbyl; X1 is O, S or NRc and X2 is ═O, ═S or ═NRc; R7 is selected from hydrogen and a C1-8 hydrocarbyl group optionally substituted by one or more substituents selected from hydroxy, oxo, halogen, cyano, nitro, amino, mono- or di-C1-4 hydrocarbylamino, carbocyclic and heterocyclic groups having from 3 to 12 ring members and wherein one or more carbon atoms of the C1-8 hydrocarbyl group may optionally be replaced by O, S, SO, SO2, NRc, X1C(X2), C(X2)X1 or X1C(X2)X1; R8 is selected from R7 and carbocyclic and heterocyclic groups having from 3 to 12 ring members; R9 is selected from R8, COR8 and SO2R8; or NR7R8 or NR7R9 may each form a heterocyclic group having from 5 to 12 ring members; but excluding the compounds N-[(morpholin-4-yl)phenyl-1H-indazole-3-carboxamide and N-[4-(acetylaminosulphonyl)phenyl-1H-indazole-3-carboxamide.

Methods and apparatus are provided for determining a defibrillation treatment protocol in an external defibrillator using a measurement of elapsed time. The present invention provides a defibrillator with a timer function. Upon activation of the defibrillator, an internal timer begins to run. By closely associating the activation of the defibrillator with the onset of the patient's attack, and by making allowances for inherent time differences between these events, the timer provides a measure of the elapsed time between the onset of the patient's emergency and the presentation of the defibrillator at the patient's side. Using this measure of elapsed time, the defibrillator determines an appropriate treatment therapy, such as CPR or defibrillation therapy.

The present invention provides a lithium secondary battery having excellent battery cycle property, electrical capacity, storage characteristic and other battery characteristics for a long period of time, and a nonaqueous electrolytic solution which is usable for the lithium secondary battery.A nonaqueous electrolytic solution in which an electrolyte salt is dissolved in a nonaqueous solvent, comprising (i) a dicarbonyl compound represented by the general formula (I), or (ii) a dicarbonyl compound represented by the general formula (II) and vinylene carbonate and the like in the nonaqueous electrolytic solution.(wherein R1 represents a hydrogen atom, an alkyl group, an alkenyl group, a phenyl group or the like; and X represents a hydrogen atom, an R2 group or an OR2 group. R2 represents an alkyl group, an alkenyl group, a phenyl group or the like.)(wherein R1 and X are the same as above; Y and Z represents a hydrogen atom, an R2 group, an OR2 group, a COR2 group or a CH2COR2 group; and n is 1 to 6.)

A mechanical chest compression device is secured to a gurney, transport stretcher or ambulance cot while engaging a patient's thorax to provide mechanical CPR during transport. The mechanical chest compression device compresses the patient's thorax against the gurney deck. The mechanical chest compression device may engage the side rails on the gurney, the gurney deck or any suitable structural elements of the gurney.

The invention discloses a posture recognition technology-based cardiopulmonary resuscitation interactive training system. The system comprises a somatosensory recognition probe and interaction software; the interaction software is installed in computer equipment; the somatosensory recognition probe is connected with the computer equipment, is subjected to the somatosensory information acquisitionof the interaction software. When the interaction software is executed by a computer, the following steps are completed: the real-time posture data of human body somatosensory are obtained through thesomatosensory recognition probe; the real-time posture data are compared with cardiopulmonary resuscitation standard posture data in a database, and a comparison result is outputted; and the comparison result is displayed on a display device. According to the system provided by the technical schemes of the invention, the posture collection of a person during cardiopulmonary resuscitation trainingcan be achieved through the somatosensory recognition probe; the collected postures can be compared with the standard cardiopulmonary resuscitation postures; the comparison result can be output; whether an action is standard or not can be checked in real time; action correction can be conducted; and training is completed. By adopting the system, professionals do not need to stay beside a user toguide the user, and the popularization of training can be facilitated.